Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Darryl C. Grendahl"'
Autor:
Nageswar R. Madde, Chung Il Wi, Timothy J. Moynihan, W. Ray Kim, Steven R. Alberts, Darryl C. Grendahl, Joseph J. Larson, Nicole M. Loo
Publikováno v:
Clinical Gastroenterology and Hepatology. 13:970-975
Chemotherapy of patients with inactive hepatitis B virus (HBV) infection can lead to viral reactivation and hepatitis flares. We investigated the proportion of patients screened for HBV infection before chemotherapy over time and the outcomes of scre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::932c61d14fe6a92029f1f4e1493f33e3
https://doi.org/10.1016/j.cgh.2014.10.032
https://doi.org/10.1016/j.cgh.2014.10.032
Autor:
Crystal Hilger, Charles L. Loprinzi, Kari J. Anderson, Kristine Sorgatz, Drew K. Seisler, Darryl C. Grendahl, Livia Hegerova, Alexis D. Leal
Publikováno v:
Supportive Care in Cancer. 23:55-59
Fosaprepitant is an antiemetic used for chemotherapy-induced nausea and vomiting. We recently reported increased infusion site adverse events (ISAE) in a cohort of breast cancer patients receiving chemotherapy with doxorubicin and cyclophosphamide (A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83406190e8a18f95ee1a048ba51fce92
https://doi.org/10.1007/s00520-014-2326-9
https://doi.org/10.1007/s00520-014-2326-9
Autor:
Darryl C. Grendahl, Nadya V. Koshkina, Allen M. Goorin, Carola A.S. Arndt, Martin L. Blakely, Mark L. Bernstein, Mark Krailo, Carrie Y. Inwards, Sharon A. Bell, Peter M. Anderson, Douglas S. Hawkins, Doojduen Villaluna, Neyssa Marina, Kaylee Ray, Eugenie S. Kleinerman
Publikováno v:
Clinical Cancer Research. 16:4024-4030
Purpose: Osteosarcoma most commonly recurs in the lung. Based on preliminary data on the antitumor effects of granulocyte-macrophage colony stimulating factor (GM-CSF) in animal models, and promising phase I trials, we embarked on a feasibility study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e6c2c11aea4dd26171e15fa40af4a3c
https://doi.org/10.1158/1078-0432.ccr-10-0662
https://doi.org/10.1158/1078-0432.ccr-10-0662
Publikováno v:
Postgraduate Medicine. 107:267-276
Pain is one of the most common problems for cancer patients, and its management is often hindered by barriers created by patients and physicians alike. By avoiding potential barriers and understanding the principles of pain management and drug select
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d76001b67953997e2e21ac3dbcdf96cf
https://doi.org/10.3810/pgm.2000.03.959
https://doi.org/10.3810/pgm.2000.03.959
Autor:
Lynn C. Hartmann, Loren K. Tschetter, Thomas M. Habermann, Larry P. Ebbert, P. Steven Johnson, James A. Mailliard, Ralph Levitt, Vera J. Suman, Thomas E. Witzig, H.S. Wieand, Langdon L. Miller, Charles G. Moertel, Darryl C. Grendahl, Dianne M. Herrera
Publikováno v:
New England Journal of Medicine. 336:1776-1780
Randomized trials of colony-stimulating factors in febrile patients with neutropenia after chemotherapy have not consistently shown clinical benefit. Nevertheless, the use of colony-stimulating factors to treat patients with chemotherapy-induced neut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a71f098fa5944acf8368bfba5cbe73f7
https://doi.org/10.1056/nejm199706193362502
https://doi.org/10.1056/nejm199706193362502
Autor:
Darryl C. Grendahl, Ayalew Tefferi
Publikováno v:
American Journal of Hematology. 52:231-233
Two patients with chronic-phase chronic granulocytic leukemia initially responded to recombinant interferon alpha-2a (rIFN-alpha-2a) but relapsed as a result of development of hightiter neutralizing antibodies to rIFN-alpha-2a. Both patients were sub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f0591158a902698c4cafdfe872d0657
https://doi.org/10.1002/(sici)1096-8652(199607)52:3<231::aid-ajh20>3.0.co
https://doi.org/10.1002/(sici)1096-8652(199607)52:3<231::aid-ajh20>3.0.co
Autor:
Charles L. Loprinzi, Joleen M. Hubbard, Darryl C. Grendahl, Nilay Shah, Andreas S. Beutler, Dierdre Pachman, Kathryn J. Ruddy, Lindsey R. Haas, Axel Grothey
Publikováno v:
Journal of Clinical Oncology. 32:e14644-e14644
e14644 Background: A retrospective analysis published in June 2004 suggested that patients who received intravenous calcium/magnesium (CaMg) were less likely to experience oxaliplatin-induced neuro...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e2cefc69f156aa393624be11303d6c6
https://doi.org/10.1200/jco.2014.32.15_suppl.e14644
https://doi.org/10.1200/jco.2014.32.15_suppl.e14644
Autor:
Darryl C. Grendahl, Kelliann C. Fee-Schroeder, Drew K. Seisler, Charles L. Loprinzi, Alexis D. Leal, Rui Qin, Kristine Sorgatz, Kunal C. Kadakia
Publikováno v:
Journal of Clinical Oncology. 31:e17538-e17538
e17538 Background: Adherence to guideline-consistent chemotherapy-induced nausea and vomiting (CINV) prophylaxis is suboptimal. The primary aim of this study was to evaluate the magnitude of compliance to institutional guideline-directed antiemetic p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab5f509768a5fb2fd8f2fc9edfd54dbe
https://doi.org/10.1200/jco.2013.31.15_suppl.e17538
https://doi.org/10.1200/jco.2013.31.15_suppl.e17538
Autor:
Darryl C. Grendahl, Alison Jacobson, Sherry A. Looker, Alexis D. Leal, Kunal C. Kadakia, Kristine Sorgatz, Charles L. Loprinzi, Timothy J. Hobday, Drew K. Seisler, Crystal Hilger, Kari J. Anderson
Publikováno v:
Journal of Clinical Oncology. 31:e20605-e20605
e20605 Background: Intravenous (IV) fosaprepitant is a potent antiemetic, commonly used in patients receiving chemotherapy. The purpose of this study was to investigate the incidence of IV fosaprepitant-associated infusion site adverse events (ISAEs)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::effbfa8492a1acd6e4277fbf31671a5d
https://doi.org/10.1200/jco.2013.31.15_suppl.e20605
https://doi.org/10.1200/jco.2013.31.15_suppl.e20605